| |
Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held on [ ], April [ ], 2024. The proxy materials are available at
https://jaguarhealth.gcs-web.com/financial-information/annual-reports |
| |
Name and address of beneficial owner
|
| |
Common Stock
|
| |
Series J
Preferred Stock |
| ||||||||||||||||||
|
Number of
Shares Beneficially Owned |
| |
Percentage
of Shares Beneficially Owned |
| |
Number of
Shares Beneficially Owned |
| |
Percentage
of Shares Beneficially Owned |
| ||||||||||||||
5% Stockholders | | | | | | | | | | | | | | | | | | | | | | | | | |
Streeterville Capital, LLC(1)
|
| | | | — | | | | | | — | | | | | | 179.3822 | | | | | | 100% | | |
Named executive officers and directors:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Lisa A. Conte(2)
|
| | | | 11,717 | | | | | | * | | | | | | — | | | | | | — | | |
Pravin Chaturvedi, Ph.D.(3)
|
| | | | 2,688 | | | | | | * | | | | | | — | | | | | | — | | |
Steven R. King, Ph.D(4)
|
| | | | 3,361 | | | | | | * | | | | | | — | | | | | | — | | |
Jonathan S. Wolin(5)
|
| | | | 2,909 | | | | | | * | | | | | | — | | | | | | — | | |
Carol Lizak(6)
|
| | | | 1,411 | | | | | | * | | | | | | — | | | | | | — | | |
James J. Bochnowski(7)
|
| | | | 6,340 | | | | | | * | | | | | | — | | | | | | — | | |
Jonathan B. Siegel(8)
|
| | | | 3,006 | | | | | | * | | | | | | — | | | | | | — | | |
John Micek III(9)
|
| | | | 2,297 | | | | | | * | | | | | | — | | | | | | — | | |
Anula Jayasuriya(10)
|
| | | | 1,718 | | | | | | * | | | | | | — | | | | | | — | | |
All current executive officers and directors as a group (9 persons)(11)
|
| | | | 35,447 | | | | | | * | | | | | | — | | | | | | — | | |
| | |
Scenario A
|
| |
Scenario B
|
| |
Scenario C
|
| |||||||||
Hypothetical Exchange Price
|
| | | $ | 0.50 | | | | | $ | 1.00 | | | | | $ | 2.00 | | |
Hypothetical Exchange Ratio
|
| | | | 50,000 | | | | | | 25,000 | | | | | | 12,500 | | |
Hypothetical Aggregate Outstanding Shares of Series J Preferred Stock
|
| | | | 179.3822 | | | | | | 179.3822 | | | | | | 179.3822 | | |
Total Number of Shares of Common Stock Issued Upon Full Exchange of Series J Preferred Stock
|
| | | | 8,969,110 | | | | | | 4,484,555 | | | | | | 2,242,278 | | |
&O:I>'_ %_6C_8U
M>GQT[UV]W.FTTWO4T/TZ:N%=Q7&]9NVP! ?.?*S3;[ZAVI8
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M9)U+HP_L:3_K'ZZ]P
3*MQEJ=KXP87;>)Q.G*ZG4@A>._G8P!Q/
MO.J[&Q#1;C'DD7-N.F*1EEN,RF_5+(OS?4/-RQ'S RS\G"T]V AT'O+2N%
MSIZ[\N^GAL*&_+5<9;C!XYN'PN.Q3 VC6AK#3_HF!O]2[:U#1!1Y(O(1HDC
M(+89$)>I#*^3A,/AFNT=;LOLO:/S:S.4:^S67[%0=9N4A&/-U\/\2OS9>5([
M?3CB_E]N97+N;H^];;"T]YCK,U!_>D
N1TXW'MY*D?.=/83-]BMNE0I&4N;)6,MC98Q71+*\^KB:5NT,#7;KY
M$F2+W^'-' \-^QSE3=5?D7>1,G
M,UT
31DLEG(*V;6EZ_TS\D] I^O&GJ?7]UK[9F\ID/NNPW%U\93S
M3I(>6O"\DGSGZ>/W*R1Y]::%0?(2QW#L7M9IR^:9O)M'KE(Z^\U"KJ^#Q2DT
M-LK07NKY_>K]2Y>I@/+6Z"-77/;?QWNW7[SKNNJX]YKT68^ZMV(RZ@GCC>\2
MB7P0Z2#;+E_9SYY&"H'J"&>L_B97[EH;/\IW[>WV*6?>H==4X7*QDLH<2E2S
M2A2&B4E*FTI,C/EZD!U:.[?&?0M2Z[M-BTU4RJ[$UR _;0]O3-D?GO3(;1OK
M4^I3AH,GC0:5EQP6? )JXNIMLF;SUKJVVV*218VM